In contrast, those on anti-TNF-α therapies had somewhat decreased tissue eotaxin-1 levels, though the later did not reach statistical significance; also no effect was seen with 5-aminosalicylates or immunomodulators ( Table S1 and S2 ).
← all excerpts
High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.
1
—
—